Unixell Biotechnology Announces the First Patient Dosed With Ux-Da001, an Investigational Autologous Ipsc Based Cell Therapy for the Treatment of Parkinson's Disease, in Its Phase 1 Study
Unixell生物科技宣佈在其一期研究中,首位患者接受了Ux-Da001的治療,這是一種針對帕金森病的研究性自體iPSC基礎電芯療法。